Is Esperion Therapeutics Worth $130? This Analyst Thinks So By: Benzinga via Benzinga March 27, 2015 at 18:17 PM EDT In a report published Friday, Citi analysts initiated coverage Esperion Therapeutics Inc (NASDAQ: ESPR) with a Buy rating and a price ... Read More >> Related Stocks: Esperion Theraptc